Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
PANACEA LIFE SCIENCES HOLDINGS, INC. (EXDI)
|
Add to portfolio |
|
|
|
| Price: |
$0.72
| | Metrics |
| OS: |
17.6
|
M
| |
|
|
| Market cap: |
$12.7
|
M
| |
|
|
|
Net debt:
|
$10.5
|
M
| |
|
|
|
EV:
|
$23.2
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| Revenues | 3.8 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | 623.4% | | | | -100.0% | -570.1% | 33.3% | |
| Cost of goods sold | 5.0 | 4.0 | 0.0 | 0.0 | 0.0 | -0.8 | 0.0 | 0.0 |
| Gross profit | -1.2 | -3.5 | 0.0 | 0.0 | 0.0 | 0.8 | 0.0 | 0.0 |
| Gross margin | -31.2% | -653.5% | | | | -19339.8% | 100.0% | 100.0% |
| Sales and marketing | 0.6 | 0.9 | 0.0 | | | | | |
| Research and development | | 0.0 | 0.3 | 0.4 | 0.4 | 0.1 | 0.1 | |
| General and administrative | 4.7 | 7.8 | 2.1 | 1.7 | 1.1 | 0.3 | 0.2 | 0.0 |
| EBITA | -9.8 | -9.8 | -2.4 | -2.1 | -1.6 | -0.4 | -0.4 | -0.2 |
| EBITA margin | -256.7% | -1861.2% | | | | 9204.9% | -49326.1% | -31546.9% |
| Amortization of intangibles | 0.7 | 0.8 | | | | | | |
| EBIT | -10.6 | -10.7 | -2.4 | -2.1 | -1.6 | -0.4 | -0.4 | -0.2 |
| EBIT margin | -275.9% | -2017.9% | | | | 9204.9% | -49326.1% | -31546.9% |
| Pre-tax income | -10.9 | -10.0 | -4.3 | -3.9 | -1.6 | -0.4 | -0.3 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Earnings from continuing ops | -9.5 | -10.4 | -4.3 | -3.9 | -1.6 | -0.4 | -0.3 | 0.0 |
| Earnings from discontinued ops | | | | | | 0.0 | | |
| Net income | -9.5 | -10.4 | -4.3 | -3.9 | -1.6 | -0.4 | -0.3 | 0.0 |
| Net margin | -247.3% | -1963.6% | | | | 8938.3% | -34808.8% | -3746.8% |
| |
| Diluted EPS | ($0.19) | ($0.31) | ($0.91) | ($0.91) | ($0.08) | ($0.70) | ($0.02) | $0.00 |
| Shares outstanding (diluted) | 49.7 | 33.9 | 4.8 | 4.2 | 19.2 | 0.5 | 13.1 | 111,485.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|